Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists
Open Access
- 1 September 2008
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 112 (5) , 1750-1758
- https://doi.org/10.1182/blood-2008-01-130500
Abstract
Neonates exhibit an increased risk of sepsis mortality compared with adults. We show that in contrast to adults, survival from polymicrobial sepsis iThis publication has 52 references indexed in Scilit:
- Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsisBlood, 2007
- Adaptive immune cells temper initial innate responsesNature Medicine, 2007
- MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsisThe Journal of Experimental Medicine, 2007
- Type I interferons protect neonates from acute inflammation through interleukin 10–producing B cellsThe Journal of Experimental Medicine, 2007
- Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cellsBlood, 2006
- ACTIVATION OF COMMON ANTIVIRAL PATHWAYS CAN POTENTIATE INFLAMMATORY RESPONSES TO SEPTIC SHOCKShock, 2006
- Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27The Journal of Experimental Medicine, 2006
- Pathogen Recognition and Innate ImmunityCell, 2006
- Type I interferon dependence of plasmacytoid dendritic cell activation and migrationThe Journal of Experimental Medicine, 2005
- Notch–RBP-J signaling is involved in cell fate determination of marginal zone B cellsNature Immunology, 2002